Skip to main content
Medacta Group SA logo

Medacta Group SA — Investor Relations & Filings

Ticker · MOVE ISIN · CH0468525222 LEI · 506700P2PFU3A3DROC14 SW Manufacturing
Open in API
Filings indexed 199 across all filing types
Latest filing 2021-07-28 Regulatory Filings
Country CH Switzerland
Listing SW MOVE

About Medacta Group SA

https://www.medacta.com/

Medacta Group SA is a medical device company that designs, manufactures, and distributes orthopaedic and neurosurgical products worldwide. Its portfolio focuses on joint replacement, spine surgery, and sports medicine. The company emphasizes innovation in minimally invasive surgical techniques and personalized patient solutions, developed through close collaboration with surgeons. A key component of its business model is the M.O.R.E. Institute, a global medical education platform that provides comprehensive training and support for healthcare professionals. Medacta is recognized for pioneering advanced surgical approaches, such as Kinematic Alignment for total knee replacement, with a focus on improving patient outcomes and healthcare sustainability.

Recent filings

Filing Released Lang Actions
Medacta Expands Hip Revision Portfolio, Unveiling Cutting-Edge Implants for Acetabulum and Femur
Regulatory Filings Classification · 1% confidence The document is titled 'News Details' and begins with a 'Media release' header. The content describes the launch and expansion of new product lines (hip revision implants) by Medacta, including technical details and quotes from the CEO and a surgeon. It is dated July 28, 2021, and is clearly a press announcement regarding a business development (product launch/expansion), not a formal regulatory financial filing like a 10-K, IR, or ER. Since it is a general corporate announcement about product news, it does not fit the specific categories like AGM-R, 10-K, ER, or CT. It is best classified as a general Regulatory Filing (RNS) as it is a news release distributed via a service (EQS Group-News) that serves as a general regulatory announcement channel when a more specific financial or governance category does not apply. The length (8818 chars) is substantial enough that it is not just a brief announcement of a report (RPA).
2021-07-28 English
Medacta Group SA reports 35.4% growth at constant currency of half-year revenue and revises upward the revenue target for 2021
Earnings Release Classification · 1% confidence The document is explicitly labeled as an "Ad-hoc" announcement released on July 20, 2021, pursuant to Art. 53 LR. It reports preliminary unaudited revenue figures for the first semester (1H 2021) and revises the revenue target for the full year 2021. This content—reporting on a specific, shorter fiscal period (half-year) with preliminary results—aligns perfectly with the definition of an Interim / Quarterly Report (IR). Although it is an announcement, its primary function is to deliver the core financial performance data for the interim period, rather than just announcing the publication of a larger, comprehensive report (which would suggest RPA or RNS). Furthermore, it mentions the upcoming announcement of the full '2021 Half-Year Results' on September 10, 2021, suggesting this document is the preliminary release of those interim figures. The document also mentions the publication of the 'Sustainability Report 2020', but the main focus and bulk of the text concern the 1H 2021 revenue performance, making IR the most appropriate classification over SR. H1 2021
2021-07-20 English
Medacta Announces Successful Completion of First Reverse Shoulder Arthroplasties using NextAR Augmented Reality Surgical Platform
Regulatory Filings Classification · 1% confidence The document is titled 'Medacta Announces Successful Completion of First Reverse Shoulder Arthroplasties using NextAR Augmented Reality Surgical Platform' and is explicitly labeled as a 'Media Release'. It details a product launch/milestone (first surgeries using a new AR platform) and includes contact information and an 'About Medacta' section, characteristic of a press release or news announcement. This type of announcement, which is not a formal regulatory filing like a 10-K, IR, or ER, but rather a general corporate update distributed via a news service (EQS Group-News), best fits the 'Regulatory Filings' (RNS) category as a general corporate disclosure that doesn't match the more specific financial or governance codes. It is not a report itself, but an announcement of an event/product success.
2021-07-14 English
Medacta Group SA announces the final settlement in the Microport case
Legal Proceedings Report Classification · 1% confidence The document is titled 'News Details' and is explicitly labeled as an 'Ad-hoc' announcement released on July 13, 2021. It announces the 'final settlement in the Microport case,' detailing financial terms ($7 million + $5 million + marketing contribution) related to resolving a patent infringement suit. This type of material, which reports on significant, non-routine legal or operational events outside of standard periodic financial reporting (like 10-K or IR), is typically disseminated via regulatory news services. Since it is a specific, material announcement that doesn't fit the definitions for ER, LTR (which is for ongoing proceedings updates), or CAP, the most appropriate general category for a material, non-standard regulatory disclosure that doesn't fit elsewhere is Regulatory Filings (RNS). The document length is short (3268 chars) and functions as a notification of an event, aligning with the spirit of an RNS filing.
2021-07-13 English
Medacta Announces the Registration of the Knee, Shoulder and Spine Applications of its NextAR Augmented Reality Surgical Platform in Europe, and the Shoulder Application to the American Market
Regulatory Filings Classification · 1% confidence The document is explicitly labeled as an "Ad-hoc" announcement released on May 27, 2021, pursuant to Art. 53 KR (likely referring to Swiss stock exchange regulations for ad-hoc disclosures). The content details the regulatory approval (CE-marking and FDA clearance) for Medacta's NextAR Augmented Reality Surgical Platform applications. This type of announcement, which communicates a significant, non-routine event (regulatory milestone) outside of standard periodic reporting cycles, fits best under the general category for regulatory announcements that aren't specifically earnings, capital changes, or director dealings. Since it is a specific regulatory update that doesn't fit the definitions for 10-K, ER, IR, CAP, or DIRS, the most appropriate fallback category is Regulatory Filings (RNS), as it is a general regulatory disclosure. It is not an Earnings Release (ER) as it discusses product approval, not financial results. It is not an Interim Report (IR) or Annual Report (10-K) as it is a short press release about a regulatory event, not a comprehensive financial statement. It is not a Report Publication Announcement (RPA) because it is the substance of the news (the approval itself), not just an announcement that a report is available.
2021-05-27 English
Medacta announces the results of today's Annual General Meeting
AGM Information Classification · 1% confidence The document is explicitly titled "Medacta announces the results of today’s Annual General Meeting" and uses the keyword 'AGM' multiple times. It details the outcomes of the meeting, including the re-election of board members and the approval of various reports (Management Report, Financial Statements, Remuneration Report). This content directly corresponds to the definition of AGM Information (AGM-R), which covers presentations and materials shared during the Annual General Meeting. Although it mentions the approval of the Annual Statutory Financial Statements, the primary focus and context is the meeting results, not the full 10-K report itself. It is not a DVA (Declaration of Voting Results) because it reports on the *approval* of proposals rather than just the final vote tally on specific resolutions, and it is clearly framed as an AGM announcement.
2021-05-25 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.